Andreia Miranda

2022202320244 21 12

Public access

4 articles

0 articles

available

not available

Based on funding mandates

José Alexandre FerreiraPortuguese Institute of Oncology of PortoVerified email at ipoporto.min-saude.pt
Andreia PeixotoPortuguese Oncology Institute of Porto Research Centre & Institute for Research and Innovation inVerified email at ipoporto.min-saude.pt
Janine SoaresIPO PortoVerified email at ipoporto.min-saude.pt
Marta Relvas-SantosPortuguese Oncology Institute of Porto Research Centre & LAQV-REQUIMTE, Faculty of Sciences of University of PortoVerified email at ipoporto.min-saude.pt
Luis LimaProfessor, Instituto Politécnico do PortoVerified email at estgf.ipp.pt
Rui FreitasPhD Student, Instituto de Ciências Biomedicas Abel Salazar; Instituto Portugues de Oncologia doVerified email at ipoporto.min-saude.pt
Cristiana GaiteiroIPO-PortoVerified email at ipoporto.min-saude.pt
Dylan FerreiraInstituto Português de Oncologia

Andreia Miranda

PhD Student, IPO-Porto

Verified email at med.up.pt


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion C Gaiteiro, J Soares, M Relvas-Santos, A Peixoto, D Ferreira, P Paulo, ... Theranostics 12 (7), 3150, 2022	18	2022
Immunomodulatory glycomedicine: Introducing next generation cancer glycovaccines R Freitas, A Peixoto, E Ferreira, A Miranda, LL Santos, JA Ferreira Biotechnology Advances, 108144, 2023	11	2023
A roadmap for translational cancer glycoimmunology at single cell resolution A Peixoto, A Miranda, LL Santos, JA Ferreira Journal of Experimental & Clinical Cancer Research 41 (1), 143, 2022	7	2022
Glycoproteogenomics characterizes the CD44 splicing code driving bladder cancer invasion C Gaiteiro, J Soares, M Relvas-Santos, A Peixoto, D Ferreira, A Brandão, ... bioRxiv, 2021.09. 04.458979, 2021	1	2021

The system can't perform the operation now. Try again later.

Articles 1–4

Citations per year